EXCLUSIVE-PFIZER, WHICH HAS SOUGHT EMERGENCY USE AUTHORISATION FOR COVID-19 VACCINE IN INDIA, SAYS OFFICIALS NOT GIVEN ENOUGH NOTICE TO ATTEND REGULATOR'S MEETINGS
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.81 USD | +0.40% | +9.49% | -3.40% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.40% | 157B | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Pfizer, Which Has Sought Emergency Use Authorisation For Covid-19 Vaccine In India, Says Officials Not Given Enough Notice To Attend Regulator's Meetings